Literature DB >> 9580929

Paradoxical pleural response to antituberculous chemotherapy and isoniazid-induced lupus. Review and report of two cases.

K Hiraoka1, N Nagata, T Kawajiri, K Suzuki, S Kurokawa, M Kido, N Sakamoto.   

Abstract

Among 28 inpatients receiving antituberculous chemotherapies including isoniazid (INH) and rifampicin, we found 2 patients with newly developing pleural effusion in the hemithorax during the initial phase of successful chemotherapy. The analysis of the effusion fluids revealed an elevated level of antinuclear antibody and a decreased level of total component, which are findings compatible with lupus pleuritis. The peripheral lymphocyte stimulation test using INH was positive in 1 patient. To the best of our knowledge, there has been no published discussion of the relationship between a paradoxical response to antituberculous treatment and INH-induced lupus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580929     DOI: 10.1159/000029251

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  3 in total

1.  A patient on RIPE therapy presenting with recurrent isoniazid-associated pleural effusions: a case report.

Authors:  Vanja Varenika; Paul D Blanc
Journal:  J Med Case Rep       Date:  2011-11-30

2.  Isoniazid causing pleural effusion.

Authors:  S K Singh; Z Ahmad; D K Pandey; V Gupta; S Naaz
Journal:  Indian J Pharmacol       Date:  2008-03       Impact factor: 1.200

3.  Contra-lateral paradoxical pleural effusion during antituberculous chemotherapy.

Authors:  Vishal Chopra; Urvinderpal Singh; Dimple Chopra
Journal:  Lung India       Date:  2008-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.